Previous Article | Next Article ![]()
J Virol, May 1998, p. 4503-4507, Vol. 72, No. 5
BioTransplant,
Received 20 August 1997/Accepted 15 January 1998
Endogenous retroviruses of swine are a concern in the use of
pig-derived tissues for xenotransplantation into humans. The nucleotide
sequence of porcine endogenous retrovirus taken from lymphocytes of
miniature swine (PERV-MSL) has been characterized. PERV-MSL is a type C
retrovirus of 8,132 bp with the greatest nucleic acid sequence identity
to gibbon ape leukemia virus and murine leukemia virus. Constitutive
production of PERV-MSL RNA has been detected in normal leukocytes and
in multiple organs of swine. The copy numbers of full-length PERV
sequences per genome (approximately 8 to 15) vary among swine strains.
The open reading frames for gag, pol, and
env in PERV-MSL have over 99% amino acid sequence identity
to those of Tsukuba-1 retrovirus and are highly homologous to those of
endogenous retrovirus of cell line PK15 (PK15-ERV). Most of the
differences in the predicted amino acid sequences of PK15-ERV and
PERV-MSL are in the SU (cell attach- ment) region of
env. The existence of these PERV clones will enable studies
of infection by endogenous retroviruses in xenotransplantation.
The use of nonhuman species as
sources of organs for human transplantation, i.e., xenotransplantation,
is considered a potential solution to the shortage of human organs and
tissues for transplantation. Advances in the biology of interspecies
transplantation have enhanced the likelihood that clinical
xenotransplantation will be performed in the near future (10, 14,
17, 37). A central concern regarding xenotransplantation is the
risk of xenosis, infection by organisms transferred with the xenograft
into both the transplant recipient and the general population (7,
13, 14). The risk of viral infection is increased in
transplantation by the presence of factors commonly associated with
viral activation, e.g., immune suppression, graft-versus-host disease,
graft rejection, viral coinfection, and cytotoxic therapies (19,
28). Swine are among the most likely source species for
xenografts for clinical use.
Type C retroviruses from cell lines of swine origin have been
characterized (1, 2, 5, 6, 15, 23, 38-40, 43); as yet, no
disease following infection by these viruses has been identified. A
recent report demonstrated that a virus from PK15 (porcine
kidney-derived) cells can infect human cells in vitro (31).
This report describes the isolation and analysis of full-length cDNA
from transcribed endogenous retroviral sequences from miniature swine
lymphocytes (PERV-MSL) and sequences from two homologous proviruses of
swine. These data allow the development of further tools for
studies of retroviruses of swine.
A clone (P (A preliminary report of some of these data was presented at the
Conference on Cross-Species Infectivity and Pathogenesis, National
Institutes of Health, Bethesda, Md., July 1997.)
PAL and PK15 cDNA library construction.
Blood samples from
normal miniature swine with three different major histocompatibility
complex (MHC) haplotypes for class I and class II antigens (swine
leukocyte antigens SLAa, SLAc, and
SLAd) were generously provided by David Sachs,
Transplantation Biology Research Center, Massachusetts General
Hospital (25, 33). Animal studies were approved by the
Institutional Animal Care Committee. Purified peripheral blood
mononuclear cells (PBMC) from miniature swine (SLAd) were
obtained from whole blood centrifuged through Histopaque 1077 (Sigma,
St. Louis, Mo.) (800 × g, 25 min). The PBMC were collected and washed and cultured in serum-free Iscove's modified Dulbecco's medium with 1% phytohemagglutinin (PHA) for 64 h.
Total RNA was extracted from the PHA-activated lymphocytes with the PUREscript RNA isolation kit (Gentra Systems, Inc., Minneapolis, Minn.). Poly(A)+ RNA was isolated from total RNA with
Dynalbeads Oligo(dT)25 (Dynal, Inc., Lake Success, N.Y.).
The PK15 cell line (ATCC CCL 33) was grown in medium M199 (Life
Technologies) containing 5% porcine serum. Following trypsinization
and collection of the cells, total RNA and poly(A)+
RNA were isolated as described above.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Identification of a Full-Length cDNA for an
Endogenous Retrovirus of Miniature Swine
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
8.8) containing an 8,132-bp XhoI Tsukuba-1
viral cDNA in pBR322 was generously provided by Iwao Suzuka (38,
39). Random fragments of the insert were generated by sonication
and subcloned into plasmid pBluescriptSK, and both strands were
sequenced twice by chain termination (model 373A automated DNA
sequencer; ABI, Foster City, Calif.). This viral sequence is referred
to as Tsukuba-1.
-agarose (New England Biolabs, Beverly, Mass.),
ligated to EcoRI/CIAP-treated ZAP Express
vector (Stratagene), and packaged (Gigapack II Gold packaging extract;
Stratagene). The packaged reaction mixture was plated with
Escherichia coli XL1-Blue cells. Each cDNA library contained
1.3 × 106 to 1.5 × 106 independent
clones.
Nucleotide sequence of the miniature swine retroviral clone PERV-MSL. The sequence of PERV-MSL is 8,132 bp long. Identification of the gag, pol, and env genes was based on BLASTN comparison searches (National Center for Biotechnology Information genetic databases). The highest overall identity to PERV-MSL was displayed by gibbon ape leukemia virus (GALV [11]), followed by several murine leukemia viruses, including Moloney murine leukemia virus (MoMuLV) (36, 41). The highest homology scores for the deduced amino acid sequences of PERV-MSL gag, pol, and env open reading frames (ORFs) by the BLASTN program were also displayed by GALV and MoMuLV (Table 1).
|
Analysis of the 5'-terminal region. Several sequence motifs which are commonly found within retroviral 5'-terminal regions can be observed in PERV-MSL. A 64-bp perfectly matched repeat region is located at nucleotides 1 to 64 and at nucleotides 8062 to 8125 in the 3'-terminal region. This region has structural similarity to the 5' long terminal repeat of murine leukemia virus (27). The tRNA primer binding site in PERV-MSL (nucleotides 138 to 155) is identical to a consensus sequence that is complementary to the last 18 nucleotides at the 3' end of the mammalian proline-encoding tRNA used by type C retroviruses (8, 18). A potential splice donor sequence (AGGTGAGG) is present in PERV-MSL at positions 380 to 387 with identity to the consensus sequence (AGGTAAGT [26, 35]) in six of eight nucleotides.
The gag region of PERV-MSL.
The sequence encoding
the N terminus of the gag-pol product (ATG, sequence
nucleotide 585) of PERV-MSL was assigned based on comparison of
homologous retroviral sequences with an ORF of 1,572 bp (nucleotides
585 to 2157). Based on sequence comparison of the amino acid sequences
of p30 from primate-derived type C viruses, the predicted terminal
amino acid of p30 in PERV-MSL is a proline encoded by a codon starting
at nucleotide 1167 (30). The 5' end of the MoMuLV
gag gene encodes the sequence
Asn
1-Met1-Gly2-Gln3-Thr4, which is identical to that encoded by the gag gene of
PERV-MSL. A stretch of highly conserved amino acids at the N termini of mammalian type C retroviral gag p30 polypeptides is found in
PERV-MSL (29, 30). A Cys-His box is encoded by PERV-MSL at
nucleotides 2061 to 2102; it resembles the conserved sequence
Cys-X-X-Cys-X-X-X-X-His-X-X-X-X-Cys present in a nucleocapsid protein
(p10) of other mammalian type C retroviruses which is required for
efficient RNA packaging into virions (16, 24).
The pol region of PERV-MSL. The gag-pol junction in PERV-MSL was identified based on sequence identity to the N-terminus-encoding gag gene of MoMuLV and GALV. The pol ORF encodes 1,194 amino acids (nucleotides 2160 to 5741). The protease (PR) polypeptide p14 separates the gag and pol proteins. The PR ORF is in the same reading frame as gag and pol, separated from gag by an amber (UAG) translational terminator. A suppressor tRNA accepting glutamine is responsible for the readthrough of this gag stop (18). This arrangement is characteristic of the murine leukemia viruses. A highly conserved sequence (Leu-Leu/Val-Asp-Thr-Gly-Ala-Asp-Lys) is found around the catalytic site of PR and is characteristic of aspartyl PRs. In PERV-MSL, a six-of-eight amino acid match (nucleotides 2232 to 2255) is observed with the canonical sequence Asp-Thr-Gly. A highly conserved sequence of the reverse transcriptase, Tyr-X-Asp-Asp, is encoded by nucleotides 3177 to 3189. The pol region contains the conserved GRD region at nucleotides 2425 to 2434 and a leucine 11 amino acids downstream of the conserved SP region (at nucleotide 2549) as found in other type C retroviruses.
The env region of PERV-MSL. Two potential ATG sequences for env are present at nucleotides 5620 and 5749. However, in PERV-MSL, the env ORF which extends from the first ATG overlaps the pol reading frame, a characteristic of the murine leukemia virus family. The size of the ORF beginning at the first ATG (1,914 bp) corresponds to the size of env genes from other type C retroviruses and has a sequence which more closely resembles a consensus Kozak sequence (21, 22) than does an ORF from the second potential ATG start site.
The PERV-MSL cell attachment (SU) polypeptide encoded by env is expected to contain both the receptor-binding domain and antigens for neutralizing antibodies; eight of nine potential glycosylation sites (Asn-X-Thr/Ser) are located in the gp70 protein. The cleavage site separating peptides gp70 and p15E is the basic amino acid sequence Arg/Lys-X-Lys-Arg (nucleotides 6931 to 6942). The region downstream of this cleavage site is part of the transmembrane peptide p15E and contains a hydrophobic stretch of 26 amino acid residues that is highly conserved in mammalian retroviruses (9). A nearly perfect match (25 of 26) of these amino acids to the murine and feline leukemia viruses is found in the sequence encoded by PERV-MSL nucleotides 7254 to 7330, 70 amino acids downstream of the basic tripeptide motif. The env sequences of PERV-MSL and PERV-PK15 (Fig. 1) differ in the VRA region and the hinge region of the SU domain, which specifies the specificity of binding of Env with cell surface receptors. This suggests that PERV-MSL and PERV-PK15 (below) differ in terms of receptor binding affinities.
|
Analysis of the 3'-terminal region. The 3'-terminal region of PERV-MSL was identified based on alignment with U3 sequences from several murine leukemia viruses. In addition, within the U3 region of retroviruses is a canonical 8-bp sequence (GGGGAATG) (42) which is present in PERV-MSL at nucleotides 7580 to 7587. Other common retroviral motifs found in PERV-MSL are a potential promoter sequence (CATAAAAG, nucleotides 8013 to 8020), a polypurine tract (nucleotides 7763 to 7774), and a poly(A) adenylation signal (AATAAA; nucleotides 8097 to 8102). The enhancer within the U3 region at the 3' long terminal repeat possesses multiple binding sites for different transcription factors, such as HSTF at nucleotide 7732, NF-E1 at nucleotides 7766 and 7834, VP-16b at nucleotide 7695, and LBP-1 at nucleotides 7804 and 7954, which is consistent with activation in hematopoietic cells with injury.
Analysis of the Tsukuba-1 sequence. Tsukuba-1 is a porcine retrovirus produced from a swine malignant-lymphoma-derived cell line, Shimozuma-1 (38, 39). The nucleotide sequences of Tsukuba-1 and PERV-MSL are identical except for 30 nucleotide differences (over 99% identity). The deduced amino acid sequences of the gag, pol, and env regions also have greater than 99% sequence identity (Table 1). The Tsukuba-1 sequence has eight nucleotides at its 5' end which are not present in the 5'-terminal region of PERV-MSL. These nucleotides presumably are part of the repeat region because they are found in the 3'-terminal region of PERV-MSL (nucleotides 8074 to 8081). The remaining 22 nucleotide differences between PERV-MSL and Tsukuba-1 were distributed throughout the sequences.
Analysis of the PK15/62-1 sequence. The PK15 retroviral cDNA clone PK15/62-1 contains only 7,333 bp (endogenous retrovirus of cell line PK15 [PK15-ERV]) due to an 809-bp deletion within the pol region (nucleotides 3510 to 4317 of PERV-MSL). A second deletion (79 bp, nucleotides 5607 to 5685 of PERV-MSL) is present. This deletion spans the carboxy terminus-encoding portion and stop codon of pol and the first 66 bp of the env ORF. The majority of differences not due to deletions are found in the SU region (env-encoded amino acids 1 to 441). Northern analysis of PK15 cells identified two RNA bands in the 7.5- to 9-kb range which hybridized with the env probe. Based on its size, clone PK15/62-1 probably contains the smaller of these RNA bands, while the larger band may represent an RNA species capable of producing infectious virions.
Determination of PERV-MSL provirus copy number. DNA from PK15 cells and PBMC from inbred miniature swine (with the SLAa, SLAc, and SLAd antigens) and outbred pigs (Yucatan strain) were digested with XbaI, blotted, and hybridized to the env probe (Fig. 2). The complex hybridization patterns observed for all of the porcine genomic DNA samples indicate the presence of multiple copies of provirus-related sequences (20, 32). The numbers of potentially full-length provirus copies are approximately 8 to 15 per genome for inbred and outbred swine (Fig. 2) and 10 to 20 in PK15 cells (data not shown).
|
Tissue expression of PERV-MSL. The env probe was used in Northern blot analysis of RNA extracted from multiple organs taken from one animal. Hybridization of PERV-MSL env with a full-length transcript species in the 8- to 9-kb range was observed in porcine liver, spleen, kidney, thymus, lymph node, and lung (Fig. 3). The intensity of this band varied depending on the tissue type. Liver, kidney, and heart transcripts became visible with longer exposures. Hybridization with a human GAPDH probe (Fig. 3B) demonstrated that equivalent amounts of RNA were loaded for each sample. The size of the full-length PERV transcript found in various tissues is similar to that obtained from both nonactivated (Fig. 3, lane 1) and PHA-activated (Fig. 3, lane 2) lymphocytes. Similar results were seen with a gag probe (data not shown). The size of the transcript is in agreement with the known size of PERV-MSL isolated from PHA-activated miniature swine lymphocytes. Additional, shorter transcripts, which might represent alternatively spliced transcripts, were found in a consistent series of patterns in some tissues: ~3-kb transcripts in lymphocytes, 2- and 7-kb transcripts in lung, and 2-kb transcripts in liver (lane 4). These transcripts suggest some degree of tissue-specific determination of PERV expression.
|
Nucleotide sequence accession number. The nucleotide sequences of PERV-MSL (AF038600), PK15-ERV (AF038601), and Tsukuba-1 (AF038599) have been submitted to GenBank.
| |
ACKNOWLEDGMENTS |
|---|
These studies were supported in part by an unrestricted research grant from BioTransplant, Inc. (J.A.F.).
We thank Christina Postema and Shanthini Muthukumar for technical assistance and David Sachs, Robert Hawley, Maggie Rosa, and Ruth Kaplan for helpful discussions.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Infectious Disease Unit, Massachusetts General Hospital, 149 13th St., Charlestown, MA 02129. Phone: (617) 726-5777. Fax: (617) 726-5411. E-mail: jfishman{at}helix.mgh.harvard.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Arida, E., and T. Hultin. 1977. Biologically active RNA in inactivated swine flu concentrate. Am. J. Public Health 67:380. |
| 2. |
Armstrong, J. A.,
J. S. Porterfield, and A. De Madrid.
1971.
C-type particles in pig kidney cell lines.
J. Gen. Virol.
10:195-198 |
| 3. | Auffray, C., and F. Rougeon. 1980. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 107:303-314[Medline]. |
| 4. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1995. In Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y. |
| 5. |
Benveniste, R. E., and G. J. Todaro.
1973.
Homology between type-C viruses of various species as determined by molecular hybridization.
Proc. Natl. Acad. Sci. USA
70:3316 |
| 6. |
Bouilant, A. M. P.,
A. S. Grieg,
M. M. Lieber, and G. J. Todaro.
1975.
Type-C virus production by a continuous line of pig oviduct cells (PFT).
J. Gen. Virol.
27:173-180 |
| 7. |
Chapman, L. E.,
T. M. Folks,
D. R. Salomon,
A. P. Patterson,
T. E. Eggerman, and P. D. Noguchi.
1995.
Xenotransplantation and xenogeneic infections.
N. Engl. J. Med.
333:1498-1501 |
| 8. |
Chen, H. R., and W. C. Barker.
1984.
Nucleotide sequences of the retroviral long terminal repeats and their adjacent regions.
Nucleic Acids Res.
12:1767-1778 |
| 9. | Cianciolo, G. J., R. J. Kipnis, and R. Synderman. 1984. Similarity between p15E of murine and feline leukemia viruses and p21 of HTLV. Nature 311:515[Medline]. |
| 10. | Deacon, T., J. Schumacher, J. Dinsmore, C. Thomas, P. Palmer, S. Kott, A. Edge, D. Penny, S. Kassissieh, P. Dempsey, and O. Isacson. 1997. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. 3:350-353[Medline]. |
| 11. | Delassus, S., P. Sonigo, and S. Wain-Hobson. 1989. Genetic organization of gibbon-ape leukemia virus. Virology 173:205-213[Medline]. |
| 12. |
Ercolani, L.,
B. Florence,
M. Denaro, and M. Alexander.
1988.
Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene.
J. Biol. Chem.
263:15335-15341 |
| 13. | Fishman, J. A. 1994. Miniature swine as organ donors for man: strategies for prevention of xenotransplant-associated infections. Xenotransplantation 1:47-57. |
| 14. | Fishman, J. A. 1997. Xenosis and xenotransplantation: addressing the infectious risks posed by an emerging technology. Kidney Int. 51:41-45. |
| 15. | Frazier, M. E. 1985. Evidence for retrovirus in miniature swine with radiation-induced leukemia or metaplasia. Arch. Virol. 83:83-97[Medline]. |
| 16. |
Green, L. M., and J. M. Berg.
1989.
A retroviral Cys-Xaa2-Cys-Xaa4-His-Xaa4-Cys peptide binds metal ions: spectroscopic studies and a proposed three-dimensional structure.
Proc. Natl. Acad. Sci. USA
86:4047-4051 |
| 17. | Groth, C. G., O. Korsgren, A. Tibell, J. Tollemar, E. Moller, J. Bolinder, J. Ostman, F. P. Reinholt, C. Hellerstrom, and A. Andersson. 1994. Transplantation of porcine fetal pancrease to diabetic patients. Lancet 344:1402-1404[Medline]. |
| 18. |
Harada, F.,
G. G. Peters, and J. E. Dahlberg.
1979.
The primer tRNA for Moloney leukemia virus DNA synthesis.
J. Biol. Chem.
254:10979-10985 |
| 19. |
Hirsch, M. S.,
S. M. Phillips,
C. Solnik,
P. H. Black,
R. S. Schwartz, and C. B. Carpenter.
1972.
Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro.
Proc. Natl. Acad. Sci. USA
69:1069-1072 |
| 20. | Irwin, D. M., T. D. Kocher, and A. C. Wilson. 1991. Evolution of the cytochrome b gene of mammals. J. Mol. Evol. 32:128-144[Medline]. |
| 21. |
Kozak, M.
1986.
Influences of mRNA secondary structure on initiation by eukaryotic ribosomes.
Proc. Natl. Acad. Sci. USA
83:2850-2854 |
| 22. | Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292[Medline]. |
| 23. | Lieber, M. M., C. J. Sherr, R. E. Benveniste, and G. J. Todaro. 1975. Biologic and immunologic properties of porcine type C virus. Virology 66:616[Medline]. |
| 24. |
Méric, C., and S. P. Goff.
1989.
Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein.
J. Virol.
63:1558-1568 |
| 25. | Metzger, J. J., G. L. Gilliland, J. K. Lunney, B. A. Osborne, S. Rudikoff, and D. H. Sachs. 1981. Transplantation in miniature swine. IX. Swine histocompatibility antigens: isolation and purification of papain-solubilized SLA antigens. J. Immunol. 127:769-775[Abstract]. |
| 26. |
Mount, S. M.
1982.
A catalogue of splice junction sequences.
Nucleic Acids Res.
10:459-472 |
| 27. |
Nikbakht, K. N.,
L. R. Boone,
P. L. Glover,
F. E. Meyer, and W. K. Yang.
1987.
Characterization of a molecular clone of RFM/Un mouse chromosomal DNA that contains a full-length endogenous murine leukemia virus-related proviral genome.
J. Gen. Virol.
68:683-693 |
| 28. |
Olding, L. B.,
F. C. Jensen, and M. B. Oldstone.
1975.
Pathogenesis of cytomegalovirus infection. I. Activation of virus from bone-derived lymphocytes by in vitro allogeneic reaction.
J. Exp. Med.
141:561-566 |
| 29. | Oroszlan, S., T. D. Copeland, R. V. Gilden, and G. J. Todaro. 1981. Structural homology of the major internal proteins of endogenous type C viruses of two distantly related species of Old World monkeys; Macaca arctoides and Colobus polykomos. Virology 115:262-271[Medline]. |
| 30. | Oroszlan, S., T. D. Copeland, G. Smythers, M. R. Summers, and R. V. Gilden. 1977. Comparative primary structure analysis of the p30 protein of woolly monkey and gibbon type C viruses. Virology 77:413-417[Medline]. |
| 31. | Patience, C., Y. Takeuchi, and R. A. Weiss. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3:276-282[Medline]. |
| 32. |
Ponte, P.,
S. Y. Ng,
J. Engel,
P. Gunning, and L. Kedes.
1984.
Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA.
Nucleic Acids Res.
12:1687-1696 |
| 33. | Sachs, D. H., G. Leight, J. Cone, S. Schwarz, L. Stuart, and S. Rosenberg. 1976. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 22:559-567[Medline]. |
| 34. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. In Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 35. | Sharp, P. A. 1981. Speculations on RNA splicing. Cell 23:643-646[Medline]. |
| 36. | Shinnick, T. M., R. A. Lerner, and J. G. Sutcliff. 1981. Nucleotide sequence of Moloney murine leukemia virus. Nature 293:543-548[Medline]. |
| 37. | Starzl, T. E., J. Fung, A. Tzakis, et al. 1993. Baboon to human liver transplantation. Lancet 341:65-71[Medline]. |
| 38. | Suzuka, I., K. Sekiguchi, and M. Kodama. 1985. Some characteristics of a porcine retrovirus from a cell line derived from swine malignant lymphomas. FEBS Lett. 183:124-128[Medline]. |
| 39. | Suzuka, I., N. Shimizu, K. Sekiguchi, H. Hoshino, M. Kodama, and K. Shimotohno. 1986. Molecular cloning of unintegrated closed circular DNA of porcine retrovirus. FEBS Lett. 198:339-343[Medline]. |
| 40. | Todaro, G. J., R. E. Benveniste, M. M. Lieber, and C. J. Sherr. 1974. Characteristics of a type C virus released from the porcine cell line PK(15). Virology 58:65-74[Medline]. |
| 41. | Tristem, M., P. Kabat, L. Lieberman, S. Linde, A. Karpas, and F. Hill. 1996. Characterization of a novel murine leukemia virus-related subgroup within mammals. J. Virol. 70:8241-8246[Abstract]. |
| 42. | Weiss, R., N. Teich, H. Varmus, and J. Coffin (ed.). 1984. In RNA tumor viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 43. |
Woods, W. A.,
T. S. Papas,
H. Hirumi, and M. A. Chirigos.
1973.
Antigenic and biochemical characterization of the C-type particle of the stable porcine kidney cell line PK-15.
J. Virol.
12:1184-1186 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|